These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 29936377)

  • 1. Optimization of LC method for the quantification of doxorubicin in plasma and urine samples in view of pharmacokinetic, biomedical and drug monitoring therapy studies.
    Maliszewska O; Plenis A; Olędzka I; Kowalski P; Miękus N; Bień E; Krawczyk MA; Adamkiewicz-Drożynska E; Bączek T
    J Pharm Biomed Anal; 2018 Sep; 158():376-385. PubMed ID: 29936377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitive Analysis of Idarubicin in Human Urine and Plasma by Liquid Chromatography with Fluorescence Detection: An Application in Drug Monitoring.
    Maliszewska O; Treder N; Olędzka I; Kowalski P; Miękus N; Bączek T; Rodzaj W; Bień E; Krawczyk MA; Plenis A
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33316898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a high-performance liquid chromatographic method with a fluorescence detector for the analysis of epirubicin in human urine and plasma, and its application in drug monitoring.
    Treder N; Maliszewska O; Olędzka I; Kowalski P; Miękus N; Bączek T; Bień E; Krawczyk MA; Adamkiewicz-Drożynska E; Plenis A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Jan; 1136():121910. PubMed ID: 31830661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An improved HPLC method for therapeutic drug monitoring of daunorubicin, idarubicin, doxorubicin, epirubicin, and their 13-dihydro metabolites in human plasma.
    Fogli S; Danesi R; Innocenti F; Di Paolo A; Bocci G; Barbara C; Del Tacca M
    Ther Drug Monit; 1999 Jun; 21(3):367-75. PubMed ID: 10365655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trace determination of anthracyclines in urine: a new high-performance liquid chromatography/tandem mass spectrometry method for assessing exposure of hospital personnel.
    Sottani C; Tranfo G; Bettinelli M; Faranda P; Spagnoli M; Minoia C
    Rapid Commun Mass Spectrom; 2004; 18(20):2426-36. PubMed ID: 15386628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a LC-FL method for the simultaneous determination of doxorubicin and celecoxib in nanoparticulate fixed dose combination (NanoFDC).
    Kozlu S; Sahin A; Calis S; Capan Y
    Pharmazie; 2017 Oct; 72(10):568-570. PubMed ID: 29441879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of Bendamustine in Human Plasma and Urine by LC-FL Methods: Application in a Drug Monitoring.
    Plenis A; Frolow A; Rekowska N; Olędzka I; Kowalski P; Bień E; Krawczyk MA; Adamkiewicz-Drożynska E; Bączek T
    Chromatographia; 2016; 79():861-873. PubMed ID: 27429473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LC-MS/MS method development for quantification of doxorubicin and its metabolite 13-hydroxy doxorubicin in mice biological matrices: Application to a pharmaco-delivery study.
    Mazzucchelli S; Ravelli A; Gigli F; Minoli M; Corsi F; Ciuffreda P; Ottria R
    Biomed Chromatogr; 2017 Apr; 31(4):. PubMed ID: 27714830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of non-liposomal and liposomal doxorubicin in plasma by LC-MS/MS coupled with an effective solid phase extraction: In comparison with ultrafiltration technique and application to a pharmacokinetic study.
    Xie Y; Shao N; Jin Y; Zhang L; Jiang H; Xiong N; Su F; Xu H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jan; 1072():149-160. PubMed ID: 29175695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A sensitive high performance liquid chromatography assay for the quantification of doxorubicin associated with DNA in tumor and tissues.
    Lucas AT; O'Neal SK; Santos CM; White TF; Zamboni WC
    J Pharm Biomed Anal; 2016 Feb; 119():122-9. PubMed ID: 26678179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of a liquid chromatography method for the simultaneous determination of several nonsteroidal anti-inflammatory drugs in human plasma for therapeutic drug monitoring.
    Helmy SA; El-Bedaiwy HM
    Ther Drug Monit; 2014 Feb; 36(1):100-7. PubMed ID: 24270045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of drug residues in urine of dogs receiving anti-cancer chemotherapy by liquid chromatography-electrospray ionization- tandem mass spectrometry: is there an environmental or occupational risk?
    Hamscher G; Mohring SA; Knobloch A; Eberle N; Nau H; Nolte I; Simon D
    J Anal Toxicol; 2010 Apr; 34(3):142-8. PubMed ID: 20406538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-performance liquid chromatographic validated assay of doxorubicin in rat plasma and tissues.
    Alvarez-Cedrón L; Sayalero ML; Lanao JM
    J Chromatogr B Biomed Sci Appl; 1999 Jan; 721(2):271-8. PubMed ID: 10052699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous quantification of pirarubicin, doxorubicin, cyclophosphamide, and vincristine in human plasma of patients with non-Hodgkin's lymphoma by LC-MS/MS method.
    Qi P; Li P; Qiao L; Xue H; Ma Y; Wei S; Yang X; Zhang H; Zhang Y; Wang Y; He S; Quan H; Zhang W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 May; 1224():123754. PubMed ID: 37229818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation and clinical evaluation of a UHPLC method with fluorescence detector for plasma quantification of doxorubicin and doxorubicinol in haematological patients.
    Pérez-Blanco JS; Fernández de Gatta Mdel M; Hernández-Rivas JM; García Sánchez MJ; Sayalero Marinero ML; González López F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Apr; 955-956():93-7. PubMed ID: 24631816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A sensitive liquid chromatography/electrospray tandem mass spectroscopy method for simultaneous quantification of a disulfide bond doxorubicin conjugation prodrug and activated doxorubicin: Application to cellular pharmacokinetic and catabolism studies.
    Zheng N; Wang X; Wang Y; Xu G; Zhang H; Dai W; He B; Zhang Q; Ji J; Wang X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Oct; 1065-1066():96-103. PubMed ID: 28957779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A sensitive and reproducible HPLC assay for doxorubicin and pirarubicin.
    Jacquet JM; Galtier M; Bressolle F; Jourdan J
    J Pharm Biomed Anal; 1992 May; 10(5):343-8. PubMed ID: 1511036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a liquid chromatography-tandem mass spectrometry method for the determination of goserelin in rabbit plasma.
    Kim MK; Lee TH; Suh JH; Eom HY; Min JW; Yeom H; Kim U; Jung HJ; Cha KH; Choi YS; Youm JR; Han SB
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Aug; 878(24):2235-42. PubMed ID: 20655813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous quantification of linezolid, tinidazole, norfloxacin, moxifloxacin, levofloxacin, and gatifloxacin in human plasma for therapeutic drug monitoring and pharmacokinetic studies in human volunteers.
    Helmy SA
    Ther Drug Monit; 2013 Dec; 35(6):770-7. PubMed ID: 24061442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of doxorubicin and metabolites in murine specimens by high-performance liquid chromatography.
    van Asperen J; van Tellingen O; Beijnen JH
    J Chromatogr B Biomed Sci Appl; 1998 Aug; 712(1-2):129-43. PubMed ID: 9698235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.